CY1108472T1 - Μεθοδος για θεραπεια βακτηριακων μολυνσεων με χρηση γεμιφλοξακινης ή ενος αλατος αυτης και ενα αντιβακτηριακο παραγοντα καρβαπενεμης - Google Patents

Μεθοδος για θεραπεια βακτηριακων μολυνσεων με χρηση γεμιφλοξακινης ή ενος αλατος αυτης και ενα αντιβακτηριακο παραγοντα καρβαπενεμης

Info

Publication number
CY1108472T1
CY1108472T1 CY20081101239T CY081101239T CY1108472T1 CY 1108472 T1 CY1108472 T1 CY 1108472T1 CY 20081101239 T CY20081101239 T CY 20081101239T CY 081101239 T CY081101239 T CY 081101239T CY 1108472 T1 CY1108472 T1 CY 1108472T1
Authority
CY
Cyprus
Prior art keywords
salt
bacterial
gemifloxacine
carbapenemis
treatment
Prior art date
Application number
CY20081101239T
Other languages
English (en)
Inventor
Nancy Niconovich
Stephen Rittenhouse
Lynn Mccloskey
Kyong-Sook Paek
Mu-Yong Kim
Original Assignee
Lg Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Life Sciences Ltd filed Critical Lg Life Sciences Ltd
Publication of CY1108472T1 publication Critical patent/CY1108472T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε μια μέθοδο θεραπευτικής αγωγής αντι-βακτηριακών μολύνσεων η οποία μέθοδος περιλαμβάνει την ξεχωριστή, ταυτόχρονη ή διαδοχική χορήγηση σε ασθενή που την έχει ανάγκη, μιας αποτελεσματικής ποσότητας γεμιφλοξακίνης ή ενός άλατος αυτής και ενός αντιβακτηριακού καρβαπενέμης.
CY20081101239T 2001-11-30 2008-10-31 Μεθοδος για θεραπεια βακτηριακων μολυνσεων με χρηση γεμιφλοξακινης ή ενος αλατος αυτης και ενα αντιβακτηριακο παραγοντα καρβαπενεμης CY1108472T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33513101P 2001-11-30 2001-11-30
EP02795443A EP1458390B1 (en) 2001-11-30 2002-11-29 A method of treating bacterial infections using gemifloxacin or a salt thereof and a carbapenem antibacterial agent

Publications (1)

Publication Number Publication Date
CY1108472T1 true CY1108472T1 (el) 2014-04-09

Family

ID=23310394

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081101239T CY1108472T1 (el) 2001-11-30 2008-10-31 Μεθοδος για θεραπεια βακτηριακων μολυνσεων με χρηση γεμιφλοξακινης ή ενος αλατος αυτης και ενα αντιβακτηριακο παραγοντα καρβαπενεμης

Country Status (13)

Country Link
US (1) US20050020567A1 (el)
EP (1) EP1458390B1 (el)
AT (1) ATE404197T1 (el)
AU (1) AU2002360216A1 (el)
CA (1) CA2468033C (el)
CY (1) CY1108472T1 (el)
DE (1) DE60228324D1 (el)
DK (1) DK1458390T3 (el)
ES (1) ES2312654T3 (el)
MX (1) MXPA04005178A (el)
NO (1) NO331599B1 (el)
PT (1) PT1458390E (el)
WO (1) WO2003045389A1 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070061895A (ko) * 2004-10-08 2007-06-14 다이닛본 스미토모 세이야꾸 가부시끼가이샤 신규의 항균 약제
US9292565B2 (en) * 2010-06-30 2016-03-22 International Business Machines Corporation Template-based recognition of food product information

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080757A (en) * 1996-06-06 2000-06-27 Pfizer Inc Antibiotic quinolones and derivatives
DE60137334D1 (de) * 2000-06-09 2009-02-26 Baylor College Medicine Kombination von antimikrobiellen wirkstoffen und bakterieller interferenz zum überziehen medizinischer vorrichtungen

Also Published As

Publication number Publication date
ES2312654T3 (es) 2009-03-01
CA2468033A1 (en) 2003-06-05
CA2468033C (en) 2008-02-12
MXPA04005178A (es) 2004-08-11
EP1458390A4 (en) 2007-07-04
DE60228324D1 (de) 2008-09-25
US20050020567A1 (en) 2005-01-27
NO331599B1 (no) 2012-02-06
WO2003045389A1 (en) 2003-06-05
PT1458390E (pt) 2008-10-02
AU2002360216A1 (en) 2003-06-10
EP1458390B1 (en) 2008-08-13
DK1458390T3 (da) 2008-12-15
NO20042660L (no) 2004-06-24
EP1458390A1 (en) 2004-09-22
ATE404197T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
PT759774E (pt) Metodo para o tratamento de infeccoes bacterianas gram-negativas por administracao de um produto de proteina bactericida indutora da permeabilidade (bip) e de um antibiotico
DE60041699D1 (de) Topische antimikrobielle zusammensetzungen
CY1108437T1 (el) Φαρμακοτεχνικες μορφες οι οποιες περιεχουν μια ενωση κεφαλοσπορινης και η χρηση τους στη θεραπεια βακτηριακων λοιμωξεων σε γατους και σκυλους
PE20001112A1 (es) Derivados de quinolina como agentes antibacterianos
NO20063105L (no) Anordning og fremgangsmate for administrering av terapeutiske midler
MXPA02001254A (es) Formulacion de moxifloxacino con sal-comun.
ES2186916T3 (es) Derivados de isoxazolina como agentes antimicrobianos.
HK1122024A1 (en) 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
RS51069B (sr) Upotreba oksikodona za tretiranje visceralnog bola
YU102503A (sh) Kondenzovani pirimidinski dhfr inhibitori kao antibakterijska sredstva
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
AP2003002942A0 (en) New derivatives of oxazolidinones as bacterial agents
BR0309757A (pt) 6-alquilideno-penemas bicìclicos como inibidores de beta-lactamases
CY1107038T1 (el) Μεθοδος θεραπειας βακτηριακων λοιμωξεων με χρηση της γεμιφλοξασινης ή ενος αλατος αυτης και ενος αντιβιοτικου β-λακταμης
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
CY1108472T1 (el) Μεθοδος για θεραπεια βακτηριακων μολυνσεων με χρηση γεμιφλοξακινης ή ενος αλατος αυτης και ενα αντιβακτηριακο παραγοντα καρβαπενεμης
DK1309336T3 (da) Laspartomycin-derivater og fremstilling og anvendelse deraf
BRPI0413770A (pt) uso isolado de tigeciclina ou em combinação com rinfampin para tratar osteomielite e/ou artrite séptica
WO2005080549A3 (de) Trioxacarcine und deren verwendung gegen infektionskrankheiten
DE60207884D1 (de) Monobactam-antibakterielle verbindungen und anwendungsverfahren
WO2005053613A3 (en) Combinations for the treatment of fungal infections
BR0307468A (pt) Derivados tiadiazinona antimicrobianos úteis no tratamento de infecções bacterianas
ATE439136T1 (de) Verfahren zur behandlung von halitose
MY140242A (en) BICYCLIC 6-ALKYLIDENE-PENEMS AS ß-LACTAMASES INHIBITORS
TH65156A (th) การบำบัดรวมกันสำหรับการรักษาเกี่ยวกับการติดเชื้อแบคทีเรีย